Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07571915 · ClinicalTrials.gov registry record · NA
Health-Related Quality of Life and Metabolic Outcomes in PCOS
A NA study, sponsored by The Cleveland Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT07571915 is a NA study that is actively recruiting participants, run by The Cleveland Clinic. The registered enrollment target is 40 participants.
The verdict
NCT07571915, a NA study, is actively recruiting participants, sponsored by The Cleveland Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The primary outcome of interest is change in PCOS health-related quality of life, while the secondary outcome of interest is change in adiposity, cardiometabolic, and inflammation biomarkers.
Interventions
- OTHER Intervention Group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2026-06-01 |
| Est. Completion | 2027-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07571915
The ClinicalTrials.gov registry entry for NCT07571915 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Intervention Group is the first listed.
NCT07571915 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07571915 about?
NCT07571915 is a clinical study titled "Health-Related Quality of Life and Metabolic Outcomes in PCOS". The primary outcome of interest is change in PCOS health-related quality of life, while the secondary outcome of interest is change in adiposity, cardiometabolic, and inflammation biomarkers.
What is the current status of trial NCT07571915?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2026-06-01. Estimated completion is 2027-12-31.
What interventions are being tested in trial NCT07571915?
The interventions under investigation include: Intervention Group (OTHER).
Who is sponsoring clinical trial NCT07571915?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.